7..intravenous anaesthesia 2

Upload: mwiliza-brenda

Post on 04-Apr-2018

221 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/31/2019 7..Intravenous Anaesthesia 2

    1/23

    INTRAVENOUS ANAESTHESIA

    E OMONGE

  • 7/31/2019 7..Intravenous Anaesthesia 2

    2/23

    Anaesthetic drugs - qualities Readily controllable

    Induction and recovery rapid

  • 7/31/2019 7..Intravenous Anaesthesia 2

    3/23

    General anaesthesiaAdjunct to surgery renders the patient

    unaware or unresponsive to pain stimuli

    Systemic

    effect on the CNS

    Intravenous agents act more rapidlyproducing unconsciousness in

    20sec.thiopental, etomidate andpropofol are used in induction ofanaesthesia

  • 7/31/2019 7..Intravenous Anaesthesia 2

    4/23

    Other induction drugs Benzodiazepines diazepam,

    midazolam( less rapid action)

    Propofol and Ketamine can be used forshort operations . Most of the otheragents need maintenance with other

    drugs Droperidol causes deep sedation and

    analgesia

  • 7/31/2019 7..Intravenous Anaesthesia 2

    5/23

    GENERAL ANAESTHESIA PARENTERAL( INTRAVENOUS )

    INHALATIONAL

  • 7/31/2019 7..Intravenous Anaesthesia 2

    6/23

    PHARMAKOKINETICS Small, hydrophobic, substituted

    aromatic or heterocyclic compounds

    Hydrophobic

    preferential partition inperfused and lipophilic brain and spinalcord anaesthesia

    Blood level fall and back diffusion inthe less well perfused muscle ,visceraand at slower rate in hydrophobic

    adipose

  • 7/31/2019 7..Intravenous Anaesthesia 2

    7/23

    KINETICS Termination redistribution out of CNS

    Blood level fall , metabolism and lipophilicity

    of drug in peripheral compartment Half-life dependent hydrophobicity ,

    metabolic clearance , and time

    t initial redistribution and subsequentmetabolism take minutes and hoursrespectively with awakening level in between

  • 7/31/2019 7..Intravenous Anaesthesia 2

    8/23

    VARIABILITY Cardiac output

    Septic shock

    Cardiomyopathy

    Age

  • 7/31/2019 7..Intravenous Anaesthesia 2

    9/23

    CONTEXT SENSITIVE HALF-TIME Modest for etomidate, propofol and

    ketamine

    Increase with infusion time fordiazepam, thiopental

    Determined by redistribution from

    active site

  • 7/31/2019 7..Intravenous Anaesthesia 2

    10/23

    BARBITURATES Derivatives of barbituric acid Sodium thiopental ,thiomylal

    ,methohexital

    Racemic mixtures withenantioselectivity

    Sodium salts

    Stability post reconstitution

    1 weekand 6 weeks respectively for thiopentaland thiomylal

    Precipitates when mixed with more

  • 7/31/2019 7..Intravenous Anaesthesia 2

    11/23

    KINETICS Duration of action dependent on

    redistribution- very high lipid solubility

    makes thiopental rapid acting Clearance influence duration following

    multiple doses

    Methohexital much rapid clearance

    Prolonged use of thiopental andthiomylal can cause long duration

    coma due to slow elimination and large

  • 7/31/2019 7..Intravenous Anaesthesia 2

    12/23

    KINETICS Methohexital outpatient, rapid return

    to consciousness where propofol is

    unavailable Elimination hepatic metabolism and

    renal excretion

    Inactive metabolites Plasma protein binding is high- Vd

    decrease in hepatic disease andcondition that decrease protein

  • 7/31/2019 7..Intravenous Anaesthesia 2

    13/23

    INDICATIONS Induction of anaesthesia- rapid

    unconsciousness in seconds, peak in 1

    minute, duration of 5-8 minutes (thiopent-al )

    Higher doses for neonates and infants

    Smaller doses for elderly and inpregnancy

    Reduce doses after diazepam premed

    Thyomylal equipotent andmethohexital is 3x more potent

  • 7/31/2019 7..Intravenous Anaesthesia 2

    14/23

    INDICATIONS Methohexital produces pain on injection

    Pain reduction by using large veins orLA

    Avoid intra-aterial injection

    Dygeusia with thiopental

    Excitement e.g tremors, hypertonus,hiccoughs with methohexital

    Rectal route x10

  • 7/31/2019 7..Intravenous Anaesthesia 2

    15/23

    SIDE EFFECTS Cerebral metabolic rate reduction

    Reduced intraocular pressure

    Dose dependent decrease BP due tovasodilatation

    Myocardial contraction reduced

    Compensatory HR rise

    Care in patients with heart disease and

    b- adrenoceptor blockers

  • 7/31/2019 7..Intravenous Anaesthesia 2

    16/23

    SIDE EFFECTS

    Respiratory depression

    Care with opiods but can be used in

    asthmatics due to little effect onbronchomotor response

  • 7/31/2019 7..Intravenous Anaesthesia 2

    17/23

    PROPOFOL

    I V

    Kinetics similar to thiopental

    Rapid recovery due to high clearance

    Metabolites from liver less active andloss via kidney

    PPB high

    Used in induction and maintanance of

    GA in short procedures

  • 7/31/2019 7..Intravenous Anaesthesia 2

    18/23

    ETOMIDATE

    Large margin of dose that causeanaesthetic effect and that which

    causes respiratory depression More rapidly metabolised than

    thiopental

    Less likely to cause prolonged hangover

    More involuntary movement duringinduction

  • 7/31/2019 7..Intravenous Anaesthesia 2

    19/23

    Etomidate

    Adrenocortical suppression seen

    Useful in day case surgery

  • 7/31/2019 7..Intravenous Anaesthesia 2

    20/23

    KETAMINE

    Resembles phencyclidine

    Produce anaesthesia like state and

    profound analgesia

    Less euphoria and sensory distortion cf.phencyclidine

    Block activation of NMDA-receptor(excitatory receptor)

  • 7/31/2019 7..Intravenous Anaesthesia 2

    21/23

    Ketamine

    IV

    Slow effect 2-5 min.

    Dissociative anaesthesia

    Sensory loss ,analgesia and amnesiaand paralysis of movement withoutactual loss of consciousnessinvoluntarymovement during induction andrecovery

  • 7/31/2019 7..Intravenous Anaesthesia 2

    22/23

    Ketamine

    BP and HR increases

    Respiration unaffected with effective

    anaesthetic doses

    Hallucinations, delirium, and irrationalbehaviour common during recovery

    Less adverse effects in children

  • 7/31/2019 7..Intravenous Anaesthesia 2

    23/23

    Midazolam

    Benzodiazepene

    Slower onset and offset of action

    Respiratory and cardiovasculardepression

    Perioperative sedative in endoscopy